Estradiol Induces Neutrophil Expansion to Promote TSC-Null Tumor Progression

Endocrinology. 2023 Jun 26;164(8):bqad093. doi: 10.1210/endocr/bqad093.

Authors

Diana C Marquez-Garban¹, Mario Morales Martinez¹, Richard J Pietras^{1

2}

Affiliations

¹ Department of Medicine, Division of Hematology-Oncology and Jonsson Comprehensive Cancer Center, University of California at Los Angeles, David Geffen School of Medicine, Los Angeles, CA 90095, USA.
² Department of Internal Medicine, Division of Cancer Research and Training, Charles Drew University School of Medicine, Los Angeles, CA 90059, USA.

PMID: 37289038
PMCID: PMC10292810 (available on 2024-06-08)
DOI: 10.1210/endocr/bqad093

No abstract available

Keywords: estrogens; lymphangioleiomyomatosis; myeloid derived suppressor cells; myelopoiesis; neutrophils; tumor microenvironment.

Publication types

Editorial
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Estradiol / pharmacology
Humans
Lymphangioleiomyomatosis* / pathology
Neoplasms* / pathology
Neutrophils
Tumor Suppressor Proteins

Substances

Estradiol
Tumor Suppressor Proteins

Grants and funding